ArticleCancers2019

MSC.sTRAIL Has Better Efficacy than MSC.FL-TRAIL and in Combination with AKTi Blocks Pro-Metastatic Cytokine Production in Prostate Cancer Cells.

Andrea Mohr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.